These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 37908314)

  • 1. Dexmedetomidine Ameliorates Cardiac Ischemia/Reperfusion Injury by Enhancing Autophagy Through Activation of the AMPK/SIRT3 Pathway.
    He H; Liu P; Li P
    Drug Des Devel Ther; 2023; 17():3205-3218. PubMed ID: 37908314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexmedetomidine Confers Protection Against Neuronal Oxygen Glucose Deprivation-Reperfusion by Regulating SIRT3 Mediated Autophagy.
    Fu Z; Pang Z; He L; Zhang L; Fan Y; Zhao C; Yang J
    Neurochem Res; 2022 Nov; 47(11):3490-3505. PubMed ID: 36042140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats.
    Hu B; Tian T; Li XT; Hao PP; Liu WC; Chen YG; Jiang TY; Chen PS; Cheng Y; Xue FS
    Redox Rep; 2023 Dec; 28(1):2158526. PubMed ID: 36738240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine alleviates Hypoxia/reoxygenation-induced mitochondrial dysfunction in cardiomyocytes via activation of Sirt3/Prdx3 pathway.
    Tan Q; Dong W; Wang Q; Gao L
    Daru; 2024 Jun; 32(1):189-196. PubMed ID: 38407745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringenin improves mitochondrial function and reduces cardiac damage following ischemia-reperfusion injury: the role of the AMPK-SIRT3 signaling pathway.
    Yu LM; Dong X; Xue XD; Zhang J; Li Z; Wu HJ; Yang ZL; Yang Y; Wang HS
    Food Funct; 2019 May; 10(5):2752-2765. PubMed ID: 31041965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine protects cardiac microvascular endothelial cells from the damage of ogd/r through regulation of the pparδ-mediated autophagy.
    Shao Q; Xia J; Wu P; Ying J
    Microcirculation; 2021 May; 28(4):e12675. PubMed ID: 33377581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoliquiritigenin attenuates myocardial ischemia reperfusion through autophagy activation mediated by AMPK/mTOR/ULK1 signaling.
    Shen L; Zhu Y; Chen Z; Shen F; Yu W; Zhang L
    BMC Cardiovasc Disord; 2024 Aug; 24(1):415. PubMed ID: 39123142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway.
    Wu ZL; Davis JRJ; Zhu Y
    Biomed Res Int; 2020; 2020():8979270. PubMed ID: 33299886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway.
    Cheng X; Hu J; Wang Y; Ye H; Li X; Gao Q; Li Z
    J Diabetes Res; 2018; 2018():3071959. PubMed ID: 30402501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1α-SIRT3 signaling.
    Yu L; Gong B; Duan W; Fan C; Zhang J; Li Z; Xue X; Xu Y; Meng D; Li B; Zhang M; Bin Zhang ; Jin Z; Yu S; Yang Y; Wang H
    Sci Rep; 2017 Jan; 7():41337. PubMed ID: 28120943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway.
    Yang K; Ma Y; Xie C; He L; Zhao H; Dai Z; Wang X
    Heliyon; 2023 Nov; 9(11):e22054. PubMed ID: 38034796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
    Chang JH; Jin MM; Liu JT
    Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis.
    Wang Z; Yao M; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zhao Y; Qian J
    Biomed Pharmacother; 2022 Oct; 154():113572. PubMed ID: 35988428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
    Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
    Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis.
    Zhang X; Li Y; Wang Y; Zhuang Y; Ren X; Yang K; Ma W; Zhong M
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in hyperlipidemic rats by inhibiting inflammation, oxidative stress and NF-κB.
    Gao W; Du L; Li N; Li Y; Wu J; Zhang Z; Chen H
    Chem Biol Drug Des; 2023 Nov; 102(5):1176-1185. PubMed ID: 37604597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin B12 alleviates myocardial ischemia/reperfusion injury via the SIRT3/AMPK signaling pathway.
    Qin Y; Shi Y; Yu Q; Yang S; Wang Y; Dai X; Li G; Cheng Z
    Biomed Pharmacother; 2023 Jul; 163():114761. PubMed ID: 37126929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
    Zhang J; Jiang H; Liu DH; Wang GN
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis.
    Chen S; Li A; Wu J; Huang Y; Zou T; Tailaiti T; Wang J
    BMC Anesthesiol; 2022 Sep; 22(1):289. PubMed ID: 36104681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine protects mice against myocardium ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS pathway.
    Sun Y; Jiang C; Jiang J; Qiu L
    Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):946-953. PubMed ID: 28556946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.